Related Experiment Video
Updated: Feb 2, 2026

Tissue Engineering: Construction of a Multicellular 3D Scaffold for the Delivery of Layered Cell Sheets
Published on: October 3, 2014
Multicellular Interactions in 3D Engineered Myocardial Tissue
Maedeh Zamani1,2, Esra Karaca1,2,3, Ngan F Huang1,2,3
1School of Medicine, The Stanford Cardiovascular Institute, Stanford University, Stanford, CA, United States.
Insights
Engineering myocardial tissue with organized multicellular structures shows promise for treating cardiovascular disease. This approach aims to improve cardiac function beyond current cell therapies by leveraging cell interactions for cardiomyocyte health.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Tissue Engineering
Background:
- Cardiovascular disease remains a primary global cause of mortality.
- Current cell therapies offer limited improvement in cardiac pumping capacity.
- Cardiomyocytes (CMs) require interaction with non-cardiomyocyte cells for optimal function.
Purpose of the Study:
- To review progress in engineering myocardial tissue with physiological multicellular organization.
- To highlight the role of non-cardiomyocyte populations in engineered heart tissue.
- To identify challenges for clinical translation of these engineered tissues.
Main Methods:
- Review of current literature on engineered myocardial tissue.
- Analysis of cell-cell interactions and paracrine signaling in engineered tissues.
- Evaluation of strategies for pre-forming physiological multicellular structures.
Main Results:
- Non-cardiomyocyte cells (endothelial cells, fibroblasts) are crucial for CM survival and function in engineered tissues.
- Paracrine factors and direct cell-cell interactions mediate beneficial effects.
- Engineered tissues with organized multicellularity show potential for enhanced cardiac repair.
Conclusions:
- Pre-formed physiological multicellular organization in engineered myocardial tissue is a promising strategy.
- Overcoming challenges in clinical translation is essential for therapeutic application.
- Further research is needed to optimize engineered heart tissue for treating cardiovascular disease.
Abstract:
Cardiovascular disease is a leading cause of death in the US and many countries worldwide. Current cell-based clinical trials to restore cardiomyocyte (CM) health by local delivery of cells have shown only moderate benefit in improving cardiac pumping capacity. CMs have highly organized physiological structure and interact dynamically with non-CM populations, including endothelial cells and fibroblasts. Within engineered myocardial tissue, non-CM populations play an important role in CM survival and function, in part by secreting paracrine factors and cell-cell interactions. In this review, we summarize the progress of engineering myocardial tissue with pre-formed physiological multicellular organization, and present the challenges toward clinical translation.
Related Concept Videos
What is Genetic Engineering?
Tissues
Exocrine Glands: Unicellular and Multicellular Glands
Heat Engines
Whenever we consider heat engines (and associated devices such as refrigerators and heat pumps), we do not use the standard sign convention for heat and work. For convenience, we assume that the symbols Qh, Qc, and W represent only the amounts of heat transferred...
Predator-Prey Interactions
Internal Combustion Engine

